94 related articles for article (PubMed ID: 12894496)
1. In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours.
Stålberg P; Granberg D; Carling T; Wilander E; Eriksson B; Gobl A; Akerström G; Rastad J; Modlin IM; Oberg K; Skogseid B
Anticancer Res; 2003; 23(3B):2227-32. PubMed ID: 12894496
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the neoplastic phenotype by transfection of phospholipase C beta 3 to neuroendocrine tumor cells.
Stålberg P; Wang S; Larsson C; Weber G; Oberg K; Gobl A; Skogseid B
FEBS Lett; 1999 May; 450(3):210-6. PubMed ID: 10359076
[TBL] [Abstract][Full Text] [Related]
3. Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1.
Weber G; Grimmond S; Lagercrantz J; Friedman E; Phelan C; Carson E; Hayward N; Jacobovitz O; Nordenskjöld M; Larsson C
Hum Genet; 1997 Jan; 99(1):130-2. PubMed ID: 9003510
[TBL] [Abstract][Full Text] [Related]
4. Assignment of the mouse homologue of a human MEN1 candidate gene, phospholipase C-beta 3 (Plcb3), to chromosome region 19B by FISH.
Gobl AE; Chowdhary BP; Shu W; Eriksson L; Larsson C; Weber G; Oberg K; Skogseid B
Cytogenet Cell Genet; 1995; 71(3):257-9. PubMed ID: 7587389
[TBL] [Abstract][Full Text] [Related]
5. Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene.
Stålberg P; Lopez-Egido JR; Wang S; Gobl A; Oberg K; Skogseid B
Biochem Biophys Res Commun; 2001 Feb; 281(1):227-31. PubMed ID: 11178984
[TBL] [Abstract][Full Text] [Related]
6. The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumours.
Weber G; Friedman E; Grimmond S; Hayward NK; Phelan C; Skogseid B; Gobl A; Zedenius J; Sandelin K; Teh BT
Hum Mol Genet; 1994 Oct; 3(10):1775-81. PubMed ID: 7849701
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13.
Lagercrantz J; Carson E; Larsson C; Nordenskjöld M; Weber G
Genomics; 1996 Feb; 31(3):380-4. PubMed ID: 8838322
[TBL] [Abstract][Full Text] [Related]
8. Localization of the human phosphatidylinositol-specific phospholipase c beta 3 gene (PLCB3) within chromosome band 11q13.
Sinke RJ; Geurts van Kessel AG
Genomics; 1995 Jan; 25(2):568-9. PubMed ID: 7789993
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of neuroendocrine tumors.
Duerr EM; Chung DC
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):1-14. PubMed ID: 17382262
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
[TBL] [Abstract][Full Text] [Related]
11. Exclusion of the phosphatidylinositol-specific phospholipase C beta 3 (PLC beta 3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene.
de Wit MJ; Landsvater RM; Sinke RJ; Geurts van Kessel A; Lips CJ; Höppener JW
Hum Genet; 1997 Jan; 99(1):133-7. PubMed ID: 9003511
[TBL] [Abstract][Full Text] [Related]
12. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C-beta 2 promotes mitosis and migration of human breast cancer-derived cells.
Bertagnolo V; Benedusi M; Brugnoli F; Lanuti P; Marchisio M; Querzoli P; Capitani S
Carcinogenesis; 2007 Aug; 28(8):1638-45. PubMed ID: 17429106
[TBL] [Abstract][Full Text] [Related]
16. Candidate genes for multiple endocrine neoplasia type 1.
Lagercrantz J; Larsson C; Grimmond S; Skogseid B; Gobl A; Friedman E; Carson E; Phelan C; Oberg K; Nordenskjöld M
J Intern Med; 1995 Sep; 238(3):245-8. PubMed ID: 7673854
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of ghrelin and its receptor in pancreatic endocrine tumours.
Ekeblad S; Lejonklou MH; Grimfjärd P; Johansson T; Eriksson B; Grimelius L; Stridsberg M; Stålberg P; Skogseid B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):115-22. PubMed ID: 17201810
[TBL] [Abstract][Full Text] [Related]
18. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
